Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dario Trapani, M.Med.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sengar M, Fundytus A, Hopman W, Pramesh CS, Radhakrishnan V, Ganesan P, Mathew A, Lombe D, Jalink M, Gyawali B, Trapani D, Roitberg F, De Vries EGE, Moja L, Ilbawi A, Sullivan R, Booth CM. Cancer Medicines: What Is Essential and Affordable in India? JCO Glob Oncol. 2022 07; 8:e2200060. PMID: 35853192.
    Citations:    Fields:    Translation:Humans
  2. Denburg AE, Fundytus A, Khan MS, Howard SC, Antillon-Klussmann F, Sengar M, Lombe D, Hopman W, Jalink M, Gyawali B, Trapani D, Roitberg F, De Vries EGE, Moja L, Ilbawi A, Sullivan R, Booth CM. Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey. JCO Glob Oncol. 2022 06; 8:e2200034. PMID: 35749676; PMCID: PMC9259119.
    Citations:    Fields:    Translation:Humans
  3. Gion M, Trapani D, Cortés A, Valenza C, Lin N, Cortés J, Curigliano G. Systemic Therapy for HER2-Positive Metastatic Breast Cancer: Moving Into a New Era. Am Soc Clin Oncol Educ Book. 2022 Apr; 42:1-11. PMID: 35671434.
    Citations: 1     Fields:    Translation:Humans
  4. Razis E, Kassapian M, Andriakopoulou C, Martei YM, Zurn SJ, Hammad N, Romero Y, Dafni U, Ilbawi AM, Trapani D. Essential medicines list in national cancer control plans: a secondary analysis from a global study. Lancet Oncol. 2022 03; 23(3):e144-154. PMID: 35240089.
    Citations:    Fields:    Translation:Humans
  5. Trapani D, Ginsburg O, Fadelu T, Lin NU, Hassett M, Ilbawi AM, Anderson BO, Curigliano G. Global challenges and policy solutions in breast cancer control. Cancer Treat Rev. 2022 Mar; 104:102339. PMID: 35074727.
    Citations: 2     Fields:    Translation:Humans
  6. Tarantino P, Gandini S, Nicolò E, Trillo P, Giugliano F, Zagami P, Vivanet G, Bellerba F, Trapani D, Marra A, Esposito A, Criscitiello C, Viale G, Curigliano G. Evolution of low HER2 expression between early and advanced-stage breast cancer. Eur J Cancer. 2022 03; 163:35-43. PMID: 35032815.
    Citations: 1     Fields:    Translation:Humans
  7. Lengyel CG, Hussain S, Seeber A, Jamil Nidhamalddin S, Trapani D, Habeeb BS, Elfaham E, Mazher SA, Seid F, Khan SZ, El Bairi K, Odhiambo A, Altuna SC, Petrillo A. FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target? Life (Basel). 2022 Jan 07; 12(1). PMID: 35054474; PMCID: PMC8778800.
    Citations:    
  8. Khan SZ, Arecco L, Villarreal-Garza C, Sirohi B, Ponde NF, Habeeb B, Brandão M, Azim HA, Chowdhury AR, Bozovic-Spasojevic I, Kovalenko I, Odhiambo A, Seid FU, Mutombo AB, Petracci F, Vidra R, Altuna SC, Petrova M, Kourie HR, Ozturk MA, Razeti MG, Lengyel CG, Talibova N, Mariamidze E, Sacardo KP, Duma N, Gyawali B, Trapani D, Tagliamento M, Lambertini M. Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast Cancer. JCO Glob Oncol. 2022 01; 8:e2100153. PMID: 35025688; PMCID: PMC8769103.
    Citations:    Fields:    Translation:Humans
  9. Trapani D, Curigliano G. Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021. Breast. 2022 Mar; 62 Suppl 1:S54-S57. PMID: 34920925; PMCID: PMC9097802.
    Citations:    Fields:    Translation:Humans
  10. Trillo Aliaga P, Trapani D, Sandoval JL, Crimini E, Antonarelli G, Vivanet G, Morganti S, Corti C, Tarantino P, Friedlaender A, Belli C, Minchella I, Locatelli M, Esposito A, Criscitiello C, Curigliano G. Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials. Cancers (Basel). 2021 Nov 20; 13(22). PMID: 34830983.
    Citations: 3     
  11. Safi M, Al-Azab M, Jin C, Trapani D, Baldi S, Adlat S, Wang A, Ahmad B, Al-Madani H, Shan X, Liu J. Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study. Front Immunol. 2021; 12:609728. PMID: 34887846; PMCID: PMC8650702.
    Citations:    Fields:    Translation:Humans
  12. van der Hage J, Sandrucci S, Audisio R, Wyld L, Søreide K, Amaral T, Audisio R, Bahadoer V, Beets G, Benstead K, Berge Nilsen E, Bol K, Brandl A, Braun J, Cufer T, Dopazo C, Edhemovic I, Eriksen JG, Fiore M, van Ginhoven T, Gonzalez-Moreno S, van der Hage J, Hutteman M, Masannat Y, Onesti EC, Rau B, De Reijke T, Rubio I, Ruurda J, Sandrucci S, Soreide K, Stattner S, Trapani D, D'Ugo D, Vriens M, Wyld L, Zahl Eriksson AG. The ESSO core curriculum committee update on surgical oncology. Eur J Surg Oncol. 2021 11; 47(11):e1-e30. PMID: 34657781.
    Citations:    Fields:    Translation:Humans
  13. Duggan C, Trapani D, Ilbawi AM, Fidarova E, Laversanne M, Curigliano G, Bray F, Anderson BO. National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis. Lancet Oncol. 2021 11; 22(11):1632-1642. PMID: 34653370.
    Citations: 5     Fields:    Translation:Humans
  14. Fundytus A, Sengar M, Lombe D, Hopman W, Jalink M, Gyawali B, Trapani D, Roitberg F, De Vries EGE, Moja L, Ilbawi A, Sullivan R, Booth CM. Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey. Lancet Oncol. 2021 10; 22(10):1367-1377. PMID: 34560006; PMCID: PMC8476341.
    Citations: 4     Fields:    Translation:Humans
  15. Trapani D, Douillard JY, Winer EP, Burstein H, Carey LA, Cortes J, Lopes G, Gralow JR, Gradishar WJ, Magrini N, Curigliano G, Ilbawi AM. The Global Landscape of Treatment Standards for Breast Cancer. J Natl Cancer Inst. 2021 09 04; 113(9):1143-1155. PMID: 33502535.
    Citations: 4     Fields:    Translation:Humans
  16. Nicolò E, Trapani D, Berton Giachetti PPM, Zagami P, Curigliano G. Fed or fasted state for oral therapies in breast cancer treatment? A comprehensive review of clinical practice recommendations. Cancer Treat Rev. 2021 Nov; 100:102281. PMID: 34500366.
    Citations:    Fields:    Translation:Humans
  17. Safi M, Al-Nusaif M, Trapani D, Mashrah MA, Kanesvaran R, Alzandani A, Al-Azab M, Mazher SA, Al-Danakh A, Liu J. Brain and heart-specific death in cancer patients: Population-based study. Cancer Med. 2021 09; 10(17):5739-5747. PMID: 34374226; PMCID: PMC8419745.
    Citations: 1     Fields:    Translation:Humans
  18. Yekedüz E, Trapani D, Xu W, de Vries EGE, Labaki C, Gyawali B, Gulati S, Nabhan C, Utkan G, Curigliano G, Choueiri TK, Ürün Y. Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors. Int J Cancer. 2021 10 01; 149(7):1455-1462. PMID: 34124786.
    Citations:    Fields:    Translation:Humans
  19. Filetti M, Trapani D, Cortellini A, Cofini V, Necozione S, Pinato DJ, Porzio G, Marchetti P, Giusti R. Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey. Support Care Cancer. 2021 Dec; 29(12):7845-7854. PMID: 34176017.
    Citations: 1     Fields:    Translation:HumansAnimals
  20. Giugliano F, Crimini E, Tarantino P, Zagami P, Uliano J, Corti C, Trapani D, Curigliano G, Ascierto PA. First line treatment of BRAF mutated advanced melanoma: Does one size fit all? Cancer Treat Rev. 2021 Sep; 99:102253. PMID: 34186441.
    Citations: 6     Fields:    Translation:HumansCells
  21. Safi M, Trapani D, Alradhi M, Shan X, Jiwei L. No Overall Survival Difference in the Immunotherapy Era for Rare Subtypes of Melanoma. Pathol Oncol Res. 2021; 27:639004. PMID: 34257604; PMCID: PMC8262132.
    Citations:    Fields:    Translation:Humans
  22. Tarantino P, Trapani D, Curigliano G. Mastering the Use of Novel Anti-HER2 Treatment Options. JCO Oncol Pract. 2021 10; 17(10):605-606. PMID: 34077256.
    Citations: 1     Fields:    
  23. Trapani D, Curigliano G. COVID-19 vaccines in patients with cancer. Lancet Oncol. 2021 06; 22(6):738-739. PMID: 34087120; PMCID: PMC8169039.
    Citations: 3     Fields:    Translation:HumansCells
  24. Lengyel CG, Hussain S, Trapani D, El Bairi K, Altuna SC, Seeber A, Odhiambo A, Habeeb BS, Seid F. The Emerging Role of Liquid Biopsy in Gastric Cancer. J Clin Med. 2021 May 13; 10(10). PMID: 34068319.
    Citations: 5     
  25. Indini A, Nigro O, Lengyel CG, Ghidini M, Petrillo A, Lopez S, Raspagliesi F, Trapani D, Khakoo S, Bogani G. Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer. Cancers (Basel). 2021 Apr 01; 13(7). PMID: 33916221.
    Citations: 3     
  26. Ghidini M, Petrillo A, Botticelli A, Trapani D, Parisi A, La Salvia A, Sajjadi E, Piciotti R, Fusco N, Khakoo S. How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches. J Clin Med. 2021 Apr 01; 10(7). PMID: 33915839.
    Citations: 3     
  27. Vernieri C, Nichetti F, Lalli L, Moscetti L, Giorgi CA, Griguolo G, Marra A, Randon G, Rea CG, Ligorio F, Scagnoli S, De Angelis C, Molinelli C, Fabbri A, Ferraro E, Trapani D, Milani A, Agostinetto E, Bernocchi O, Catania G, Vantaggiato A, Palleschi M, Moretti A, Basile D, Cinausero M, Ajazi A, Castagnoli L, Lo Vullo S, Gerratana L, Puglisi F, La Verde N, Arpino G, Rocca A, Ciccarese M, Pedersini R, Fabi A, Generali D, Losurdo A, Montemurro F, Curigliano G, Del Mastro L, Michelotti A, Cortesi E, Guarneri V, Pruneri G, Mariani L, de Braud F. Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET). Clin Cancer Res. 2021 06 15; 27(12):3443-3455. PMID: 33785482.
    Citations:    Fields:    Translation:Humans
  28. Tarantino P, Mazzarella L, Marra A, Trapani D, Curigliano G. The evolving paradigm of biomarker actionability: Histology-agnosticism as a spectrum, rather than a binary quality. Cancer Treat Rev. 2021 Mar; 94:102169. PMID: 33652262.
    Citations: 1     Fields:    Translation:Humans
  29. Trapani D, Curigliano G. The global landscape of drug development of trastuzumab biosimilars. J Cancer Policy. 2021 06; 28:100273. PMID: 35559916.
    Citations:    Fields:    Translation:Humans
  30. Tarantino P, Gandini S, Trapani D, Criscitiello C, Curigliano G. Immunotherapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: A systematic review and meta-analysis of randomized clinical trials. Crit Rev Oncol Hematol. 2021 Mar; 159:103223. PMID: 33482345.
    Citations: 12     Fields:    Translation:Humans
  31. Petrillo A, Salati M, Trapani D, Ghidini M. Circulating Tumor DNA as a Biomarker for Outcomes Prediction in Colorectal Cancer Patients. Curr Drug Targets. 2021; 22(9):1010-1020. PMID: 33155906.
    Citations:    Fields:    Translation:Humans
  32. Ghidini M, Fusco N, Salati M, Khakoo S, Tomasello G, Petrelli F, Trapani D, Petrillo A. The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy. Curr Drug Targets. 2021; 22(9):1021-1033. PMID: 33563194.
    Citations: 1     Fields:    Translation:HumansCells
  33. Trapani D, Curigliano G. How to treat lobular cancer in the adjuvant setting? Curr Opin Oncol. 2020 11; 32(6):561-567. PMID: 32826487.
    Citations: 1     Fields:    Translation:Humans
  34. Elit L, Haruyama R, Gatti A, Howard SC, Lam CG, Fidarova E, Angioli R, Cao X, Trapani D, Ilbawi A. Examining policy cohesion for cervical cancer worldwide: analysis of WHO country reports. ESMO Open. 2020 11; 5(6):e000878. PMID: 33310778.
    Citations: 1     Translation:Humans
  35. Corti C, Crimini E, Criscitiello C, Trapani D, Curigliano G. Adjuvant treatment of early male breast cancer. Curr Opin Oncol. 2020 11; 32(6):594-602. PMID: 32852309.
    Citations: 1     Fields:    Translation:Humans
  36. Lemine Sow M, El Yacoubi H, Moukafih B, Balde S, Akimana G, Najem S, El Khoyaali S, Abahssain H, Chaibi A, Zeb Khan S, Trapani D, Benzekri A, Ghaouti M, Gamra L, Mestari A, Kettani F, Rahali Y, Mrabti H, Elghissassi I, Errihani H. Frequency and types of EGFR mutations in Moroccan patients with non-small cell lung cancer. Tumori. 2021 Aug; 107(4):335-340. PMID: 33079008.
    Citations: 2     Fields:    Translation:Humans
  37. Marra A, Trapani D, Viale G, Criscitiello C, Curigliano G. Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies. NPJ Breast Cancer. 2020; 6:54. PMID: 33088912.
    Citations: 38     
  38. Ottaviano M, Curvietto M, Rescigno P, Tortora M, Palmieri G, Giannarelli D, Aieta M, Assalone P, Attademo L, Avallone A, Bloise F, Bosso D, Borzillo V, Buono G, Calderoni G, Caputo F, Cartenì G, Cavallero D, Cavo A, Ciardiello F, Conca R, Conteduca V, De Falco S, De Felice M, De Laurentiis M, De Placido P, De Placido S, De Santo I, De Stefano A, Della Corte CM, Di Franco R, Di Lauro V, Fabbrocini A, Federico P, Festino L, Giordano P, Giuliano M, Gridelli C, Grimaldi AM, Lia M, Marretta AL, Massa V, Mennitto A, Merler S, Merz V, Messina C, Messina M, Milano M, Minisini AM, Montesarchio V, Morabito A, Morgillo F, Mucci B, Nappi L, Napolitano F, Paciolla I, Pagliuca M, Palmieri G, Parola S, Pepe S, Petrillo A, Piantedosi F, Piccin L, Picozzi F, Pietroluongo E, Pignata S, Prati V, Riccio V, Rosanova M, Rossi A, Russo A, Salati M, Santabarbara G, Sbrana A, Simeone E, Silvestri A, Spada M, Tarantino P, Taveggia P, Tomei F, Vincenzo T, Trapani D, Trojanello C, Vanella V, Vari S, Ventriglia J, Vitale MG, Vitiello F, Vivaldi C, von Arx C, Zacchi F, Zampiva I, Zivi A, Daniele B, Ascierto PA. Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists. J Immunother Cancer. 2020 10; 8(2). PMID: 33060148.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  39. El Bairi K, Trapani D, Petrillo A, Le Page C, Zbakh H, Daniele B, Belbaraka R, Curigliano G, Afqir S. Repurposing anticancer drugs for the management of COVID-19. Eur J Cancer. 2020 12; 141:40-61. PMID: 33125946.
    Citations: 23     Fields:    Translation:HumansCellsPHPublic Health
  40. Trapani D, Zagami P, Nicolò E, Pravettoni G, Curigliano G. Management of Cardiac Toxicity Induced by Chemotherapy. J Clin Med. 2020 Sep 07; 9(9). PMID: 32906611.
    Citations: 6     
  41. Willenbacher E, Khan SZ, Mujica SCA, Trapani D, Hussain S, Wolf D, Willenbacher W, Spizzo G, Seeber A. Erratum: Willenbacher, E., et al. Curcumin: New Insights into an Ancient Ingredient against Cancer. Int. J. Mol. Sci. 2019, 20, 1808. Int J Mol Sci. 2020 08 10; 21(16). PMID: 32785029.
    Citations: 2     Fields:    
  42. Duso BA, Trapani D, Marra A, D'Amico P, Guerini Rocco E, Fusco N, Mazzarella L, Criscitiello C, Esposito A, Curigliano G. Pharmacological management of male breast cancer. Expert Opin Pharmacother. 2020 Aug; 21(12):1493-1504. PMID: 32496137.
    Citations:    Fields:    Translation:HumansCells
  43. El Bairi K, Jabi R, Trapani D, Boutallaka H, Ouled Amar Bencheikh B, Bouziane M, Amrani M, Afqir S, Maleb A. Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut. Expert Rev Clin Pharmacol. 2020 Apr; 13(4):403-421. PMID: 32308061.
    Citations: 2     Fields:    Translation:HumansAnimals
  44. Pietrantonio F, Loupakis F, Randon G, Raimondi A, Salati M, Trapani D, Pagani F, Depetris I, Maddalena G, Morano F, Corallo S, Prisciandaro M, Corti F, Guarini V, Bocconi A, Marra A, Belli C, Spallanzani A, Fassan M, Lonardi S, Curigliano G, Fucà G, Di Bartolomeo M, de Braud F. Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden. Oncologist. 2020 09; 25(9):803-809. PMID: 32369650; PMCID: PMC7485362.
    Citations: 8     Fields:    Translation:Humans
  45. de Azambuja E, Trapani D, Loibl S, Delaloge S, Senkus E, Criscitiello C, Poortman P, Gnant M, Di Cosimo S, Cortes J, Cardoso F, Paluch-Shimon S, Curigliano G. ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer. ESMO Open. 2020 05; 5(Suppl 3). PMID: 32439716.
    Citations: 58     Translation:HumansCellsPHPublic Health
  46. Trapani D, Marra A, Curigliano G. The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region. Eur J Cancer. 2020 06; 132:199-206. PMID: 32380430.
    Citations: 29     Fields:    Translation:HumansCellsPHPublic Health
  47. Trapani D, Curigliano G. How can biosimilars change the trajectory of breast cancer therapy? Expert Rev Anticancer Ther. 2020 05; 20(5):325-328. PMID: 32298188.
    Citations: 3     Fields:    Translation:Humans
  48. Tarantino P, Hamilton E, Tolaney SM, Cortes J, Morganti S, Ferraro E, Marra A, Viale G, Trapani D, Cardoso F, Penault-Llorca F, Viale G, Andrè F, Curigliano G. HER2-Low Breast Cancer: Pathological and Clinical Landscape. J Clin Oncol. 2020 06 10; 38(17):1951-1962. PMID: 32330069.
    Citations: 32     Fields:    Translation:Humans
  49. Tarantino P, Trapani D, Curigliano G. Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease pandemic. Eur J Cancer. 2020 06; 132:8-10. PMID: 32305011.
    Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
  50. Mazzarella L, Morganti S, Marra A, Trapani D, Tini G, Pelicci P, Curigliano G. Master protocols in immuno-oncology: do novel drugs deserve novel designs? J Immunother Cancer. 2020 03; 8(1). PMID: 32238471.
    Citations: 5     Fields:    Translation:Humans
  51. Passaro A, Mackenzie G, Lambertini M, Morgan G, Zimmermann S, Garrido P, Curigliano G, Trapani D. European Society for Medical Oncology (ESMO) 2018 Congress Twitter analysis: from ethics to results through the understanding of communication and interaction flows. ESMO Open. 2020 02; 5(1). PMID: 32133983.
    Citations: 1     Translation:Humans
  52. Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, Burger EA, Martin D, Nguyen DTN, Bénard É, Sy S, Regan C, Drolet M, Gingras G, Laprise JF, Torode J, Smith MA, Fidarova E, Trapani D, Bray F, Ilbawi A, Broutet N, Hutubessy R. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020 02 22; 395(10224):591-603. PMID: 32007142; PMCID: PMC7043006.
    Citations: 97     Fields:    Translation:HumansPHPublic Health
  53. Lengyel CG, Altuna SC, Habeeb BS, Trapani D, Khan SZ. The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas. Curr Drug Targets. 2020; 21(10):946-961. PMID: 31752654.
    Citations: 5     Fields:    Translation:HumansCells
  54. Curigliano G, Bagnardi V, Ghioni M, Louahed J, Brichard V, Lehmann FF, Marra A, Trapani D, Criscitiello C, Viale G. Expression of tumor-associated antigens in breast cancer subtypes. Breast. 2020 Feb; 49:202-209. PMID: 31869767.
    Citations: 7     Fields:    Translation:Humans
  55. Trapani D, Curigliano G, Eniu A. Breast Cancer: Reimbursement Policies and Adoption of New Therapeutic Agents by National Health Systems. Breast Care (Basel). 2019 Dec; 14(6):373-381. PMID: 31933583; PMCID: PMC6940432.
    Citations: 1     
  56. Ferraro E, Trapani D, Marrucci E, Curigliano G. Evaluating triptorelin as a treatment option for breast cancer. Expert Opin Pharmacother. 2019 Oct; 20(15):1809-1818. PMID: 31500470.
    Citations:    Fields:    Translation:Humans
  57. Eniu A, Cherny NI, Bertram M, Thongprasert S, Douillard JY, Bricalli G, Vyas M, Trapani D. Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough? ESMO Open. 2019; 4(4):e000483. PMID: 31423334; PMCID: PMC6677966.
    Citations: 5     
  58. Mazzarella L, Duso BA, Trapani D, Belli C, D'Amico P, Ferraro E, Viale G, Curigliano G. The evolving landscape of 'next-generation' immune checkpoint inhibitors: A review. Eur J Cancer. 2019 08; 117:14-31. PMID: 31229946.
    Citations: 32     Fields:    Translation:HumansAnimals
  59. Trapani D, Rajasekar AKA, Mathew A. More options for adjuvant treatment of HER2-positive breast cancer: How to choose wisely? Int J Cancer. 2019 12 01; 145(11):2901-2906. PMID: 31107981.
    Citations: 4     Fields:    Translation:Humans
  60. Willenbacher E, Khan SZ, Mujica SCA, Trapani D, Hussain S, Wolf D, Willenbacher W, Spizzo G, Seeber A. Curcumin: New Insights into an Ancient Ingredient against Cancer. Int J Mol Sci. 2019 Apr 12; 20(8). PMID: 31013694.
    Citations: 35     Fields:    Translation:HumansAnimalsCells
  61. Tarantino P, Trapani D, Morganti S, Ferraro E, Viale G, D'Amico P, Duso BA, Curigliano G. Opportunities and challenges of implementing Pharmacogenomics in cancer drug development. Cancer Drug Resist. 2019; 2(1):43-52. PMID: 35582141; PMCID: PMC9019172.
    Citations: 1     
  62. Morganti S, Tarantino P, Ferraro E, D'Amico P, Viale G, Trapani D, Duso BA, Curigliano G. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life. Crit Rev Oncol Hematol. 2019 Jan; 133:171-182. PMID: 30661654.
    Citations: 25     Fields:    Translation:Humans
  63. Belli C, Zuin M, Mazzarella L, Trapani D, D'Amico P, Guerini-Rocco E, Achutti Duso B, Curigliano G. Liver toxicity in the era of immune checkpoint inhibitors: A practical approach. Crit Rev Oncol Hematol. 2018 Dec; 132:125-129. PMID: 30447917.
    Citations: 6     Fields:    Translation:Humans
  64. Romero Y, Trapani D, Johnson S, Tittenbrun Z, Given L, Hohman K, Stevens L, Torode JS, Boniol M, Ilbawi AM. National cancer control plans: a global analysis. Lancet Oncol. 2018 10; 19(10):e546-e555. PMID: 30268693.
    Citations: 32     Fields:    Translation:Humans
  65. Belli C, Trapani D, Viale G, D'Amico P, Duso BA, Della Vigna P, Orsi F, Curigliano G. Targeting the microenvironment in solid tumors. Cancer Treat Rev. 2018 Apr; 65:22-32. PMID: 29502037.
    Citations: 126     Fields:    Translation:HumansAnimals
  66. Duso BA, Trapani D, Viale G, Criscitiello C, D'Amico P, Belli C, Mazzarella L, Locatelli M, Minchella I, Curigliano G. Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer. Expert Opin Pharmacother. 2018 Feb; 19(3):299-305. PMID: 29355400.
    Citations: 2     Fields:    Translation:HumansCells
  67. Trapani D, Esposito A, Criscitiello C, Mazzarella L, Locatelli M, Minchella I, Minucci S, Curigliano G. Entinostat for the treatment of breast cancer. Expert Opin Investig Drugs. 2017 Aug; 26(8):965-971. PMID: 28718331.
    Citations: 19     Fields:    Translation:HumansAnimals
  68. Viale G, Trapani D, Curigliano G. Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy. Biomed Res Int. 2017; 2017:4719194. PMID: 28770222.
    Citations: 32     Fields:    Translation:HumansCells
  69. Esposito A, Criscitiello C, Trapani D, Curigliano G. The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations. Curr Oncol Rep. 2017 Jan; 19(1):1. PMID: 28110461.
    Citations: 19     Fields:    Translation:HumansCells
  70. Criscitiello C, Esposito A, Trapani D, Curigliano G. Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer. Cancer Treat Rev. 2016 Nov; 50:205-207. PMID: 27744144.
    Citations: 24     Fields:    Translation:HumansCells
  71. Migali C, Milano M, Trapani D, Criscitiello C, Esposito A, Locatelli M, Minchella I, Curigliano G. Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond. Ther Adv Med Oncol. 2016 Sep; 8(5):360-74. PMID: 27583028; PMCID: PMC4981297.
    Citations: 19     
  72. Trapani D, Bonzi M. Antibiotic treatment strategies for community-acquired pneumonia in adults. Intern Emerg Med. 2015 Oct; 10(7):861-3. PMID: 26293829.
    Citations: 1     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Trapani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (223)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.